비교리스트

 카트 문의
시장보고서
상품코드
1625425

소화기 관련 제품 시장 : 규모, 점유율, 동향, 산업 분석 보고서-디바이스별, 질병별, 최종 사용자별, 지역별-시장 예측(2025-2034년)

Gastrointestinal Products Market Size, Share, Trends, Industry Analysis Report: By Devices, Disease, End User, and Region - Market Forecast, 2025-2034
발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 128 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면 소화기 관련 제품 시장 규모는 2034년까지 258억 5,000만 달러에 이를 것으로 예상됩니다. 이 보고서는 현재 시장 역학을 상세하게 파악하고 미래 시장 성장에 대한 분석을 제공합니다.

위식도 역류증(GERD), 염증성 장 질환(IBD), 과민성 장 증후군(IBS) 등 위장 질환의 유병률 증가는 소화기 관련 제품 시장의 성장을 견인하는 일반적인 질병 중 하나입니다. 이러한 질병은 흔해지고 있기 때문에 효과적인 치료에 대한 수요가 높아지고 있으며, 제약 회사는 제품 라인업의 충실을 도모하고 있습니다. 또한 드래그 제제 및 약물전달 시스템의 혁신은 보다 효과적이고 환자가 사용하기 쉬운 치료법을 개발하여 컴플라이언스를 향상시킵니다. 소화기계의 건강에 대한 의식 증가와 조기 개입의 중요성은 이러한 추세를 더욱 강화하고 환자가 인사이트에 이르는 치료 옵션을 적시에 요구하도록 촉구하고 있습니다.

원격 의료 플랫폼, 전자 의료 기록(EHR), 모바일 헬스 용도 등, 특히 원격 의료 및 디지털 헬스 기술을 통한 헬스케어의 기술 통합은 소화기 케어의 상황을 변화시키고 있습니다. 이러한 기술 혁신은 환자의 의료 서비스에 대한 액세스를 향상시켜 원격 진단 및 소화기 질환의 효과적인 관리를 가능하게 합니다. 환자는 의료 전문가로부터 적시에 진단과 지속적인 지원을 직접 방문하지 않고 받을 수 있으며, 이는 특히 원격지에 사는 사람들에게 유용합니다. 또한 모바일 건강 앱과 같은 디지털 도구를 통해 환자는 자신의 증상을 모니터링하고, 식습관을 추적하고, 개인화된 치료 계획을 받을 수 있으며, 더 나은 건강 결과를 촉진할 수 있습니다. 따라서 이러한 변화는 환자의 편의성을 향상시키고 위장 건강 관리에 대한 적극적인 접근을 촉진하며 궁극적으로 만족도와 컴플라이언스 향상에 기여합니다.

소화기 관련 제품 시장 보고서 하이라이트

질병별로, 2024년에는 위식도 역류증(GERD)이 광범위한 유병률과 사회적 인지 증가로 세계 소화기 관련 제품 시장의 주요 부문으로 부상하고 있습니다.

외래수술센터(ASC)(ASCs) 분야는 외래 수술에 대한 선호도가 높아짐에 따라 소화기 관련 제품 시장에서 급성장하고 있습니다.

2024년 북미는 위식도 역류증(GERD)과 염증성 장 질환(IBD) 등 소화기 질환의 유행이 주인으로 소화기 관련 제품 시장을 선도했습니다.

아시아태평양은 건강 관리 지출 증가, 위장 건강에 대한 의식 증가, 생활 습관과 관련된 문제를 다루는 인구 증가 등을 배경으로 예측 기간 동안 가장 빠르게 성장할 것으로 예측됩니다.

세계 주요 시장 진출 기업으로는 Abbott Laboratories; Johnson & Johnson; Pfizer Inc.; Bayer AG; Astellas Pharma Inc.; Takeda Pharmaceutical Company; Novartis International AG; GSK(GlaxoSmithKline); Mylan NV; Dr.

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 세계의 소화기 관련 제품 시장 인사이트

  • 시장 현황
  • 소화기 관련 제품 시장 역학
    • 성장 촉진요인 및 기회
      • 위장 질환의 이환율 증가
      • 예방 헬스케어 및 조기 개입에 대한 주목의 고조
    • 억제요인 및 과제
      • GI 제품에 대한 엄격한 규제 정책
  • PESTEL 분석
  • 소화기 관련 제품 관련 시장의 용도 동향
  • 밸류체인 분석
  • COVID-19의 영향 분석

제5장 세계의 소화기 관련 제품 시장 : 디바이스별

  • 주요 조사 결과
  • 서문
  • 내시경 검사
  • 어블레이션 시스템
  • 운동 능력 검사
  • 생검 기기
  • 스텐트 디바이스
  • pH 모니터링 장치
  • 기타 소화기과 기기

제6장 세계의 소화기 관련 제품 시장 : 질환별

  • 주요 조사 결과
  • 서문
  • 염증성 장질환(IBD)
  • 위식도 역류증(GERD)
  • 과민성 장 증후군(IBS)
  • 소화기 암
  • 기타 병

제7장 세계의 소화기 관련 제품 시장 : 최종 사용자별

  • 주요 조사 결과
  • 서문
  • 병원
  • 외래수술센터(ASC) 및 독립 진단센터
  • 클리닉
  • 기타 최종 사용자

제8장 세계의 소화기 관련 제품 시장 : 지역별

  • 주요 조사 결과
  • 서문
    • 소화기 관련 제품 시장 평가 : 지역별(2020-2034년)
  • 북미
    • 북미 : 디바이스별(2020-2034년)
    • 북미 : 질병별(2020-2034년)
    • 북미 : 최종 사용자별(2020-2034년)
    • 미국
    • 캐나다
  • 유럽
    • 유럽 : 디바이스별(2020-2034년)
    • 유럽 : 질병별(2020-2034년)
    • 유럽 : 최종 사용자별(2020-2034년)
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 아시아태평양 : 디바이스별(2020-2034년)
    • 아시아태평양 : 질병별(2020-2034년)
    • 아시아태평양 : 최종 사용자별(2020-2034년)
    • 중국
    • 인도
    • 말레이시아
    • 일본
    • 인도네시아
    • 한국
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 중동 및 아프리카 : 디바이스별(2020-2034년)
    • 중동 및 아프리카 : 질병별(2020-2034년)
    • 중동 및 아프리카 : 최종 사용자별(2020-2034년)
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 남아프리카
    • 기타 중동 및 아프리카
  • 라틴아메리카
    • 라틴아메리카 : 디바이스별(2020-2034년)
    • 라틴아메리카 : 질병별(2020-2034년)
    • 라틴아메리카 : 최종 사용자별(2020-2034년)
    • 멕시코
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카

제9장 경쟁 구도

  • 확대 및 인수 분석
    • 확대
    • 인수
  • 제휴, 협업, 합의 및 공개

제10장 기업 프로파일

  • Abbott Laboratories
  • Johnson & Johnson
  • Pfizer Inc.
  • Bayer AG
  • Astellas Pharma Inc.
  • Takeda Pharmaceutical Company
  • Novartis International AG
  • GSK(GlaxoSmithKline)
  • Mylan NV
  • Santen Pharmaceutical Co., Ltd.
  • Dr. Reddy's Laboratories Ltd.
AJY 25.02.10

The gastrointestinal products market size is expected to reach USD 25.85 billion by 2034, according to a new study by Polaris Market Research. The report "Gastrointestinal Products Market Size, Share, Trends, Industry Analysis Report: By Devices, Disease, End User (Hospitals, Ambulatory Centers and Independent Diagnostic Centers, Clinics, Other End Users), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising prevalence of gastrointestinal disorders, such as gastroesophageal reflux disease (GERD), inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS), are among the prevailing diseases driving the gastrointestinal products market growth. Since these conditions have become more common, there is a greater demand for effective treatments, prompting pharmaceutical companies to enhance their product offerings. Additionally, innovations in drug formulations and delivery systems have led to the development of therapies that are more effective and easier for patients to use, thereby improving compliance. This growing awareness of digestive health and the importance of early intervention further reinforces this trend, encouraging patients to seek timely treatment options led to insights.

Technological integration in healthcare, such as telemedicine platforms, electronic health records (EHRs), and mobile health applications, particularly through telemedicine and digital health technologies, is transforming the landscape of gastrointestinal care. These innovations enhance patient access to medical services, enabling remote consultations and effective management of gastrointestinal disorders. Patients are now able to receive timely diagnoses and ongoing support from healthcare professionals without the need for in-person visits, which is especially beneficial for those living in remote areas. Additionally, digital tools such as mobile health apps allow patients to monitor their symptoms, track dietary habits, and receive personalized treatment plans, promoting better health outcomes. Therefore, this shift has improved patient convenience, promoting a proactive approach to gastrointestinal health management and ultimately contributing to increased satisfaction and compliance.

Gastrointestinal Products Market Report Highlights

In terms of disease, in 2024, gastroesophageal reflux disease (GERD) has emerged as the leading segment in the global gastrointestinal products market due to its widespread prevalence and growing public awareness.

The ambulatory surgical centers (ASCs) segment is witnessing rapid growth in the gastrointestinal products market, driven by an increasing preference for outpatient procedures.

In 2024, North America led the gastrointestinal products market, largely due to the prevalence of gastrointestinal disorders such as gastroesophageal reflux disease (GERD) and inflammatory bowel disease (IBD).

Asia Pacific is projected to experience the fastest growth during the forecast period, driven by increasing healthcare spending, heightened awareness of gastrointestinal health, and a rising population grappling with lifestyle-related issues.

A few global key market players include Abbott Laboratories; Johnson & Johnson; Pfizer Inc.; Bayer AG; Astellas Pharma Inc.; Takeda Pharmaceutical Company; Novartis International AG; GSK (GlaxoSmithKline); Mylan N.V.; Santen Pharmaceutical Co., Ltd.; Dr. Reddy's Laboratories Ltd.

Polaris Market Research has segmented the gastrointestinal products market report on the basis of devices, disease, end user, and region:

By Devices Outlook (Revenue, USD Billion, 2020-2034)

  • Endoscopy
  • Colonoscopy
  • Sigmoidoscopes
  • Capsule endoscopy systems
  • Other endoscopy devices/accessories
  • Ablation system
  • Radiofrequency Ablation system
  • Microwave Ablation system
  • Cryoablation system
  • Other ablation system
  • Motility testing
  • Esophageal Manometry
  • 4-hour pH impedance testing
  • Anorectal Manometry
  • Other Motility testing
  • Biopsy Devices
  • Needle Biopsy Devices
  • Endoscopic mucosal resection (EMR) devices
  • Endoscopic submucosal dissection (ESD) devices
  • Other Biopsy accessory products
  • Stenting Devices
  • pH monitoring devices
  • Other gastroenterology devices

By Disease Outlook (Revenue, USD Billion, 2020-2034)

  • Inflammatory Bowel Disease (IBD)
  • Gastroesophageal reflux disease (GERD)
  • Irritable bowel syndrome (IBS)
  • Gastrointestinal cancer
  • Other diseases

By End User Outlook (Revenue, USD Billion, 2020-2034)

  • Hospitals
  • Ambulatory surgical centres and Independent diagnostic centres
  • Clinics
  • Other end users

By Regional Outlook (Revenue, USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Vietnam
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Gastrointestinal Products Market Insights

  • 4.1. Gastrointestinal Products Market - Market Snapshot
  • 4.2. Gastrointestinal Products Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increased Prevalence of Gastrointestinal Disorders
      • 4.2.1.2. Growing Focus on Preventive Healthcare and Early Intervention
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Stringent Regulatory Policies for GI Products
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Gastrointestinal Products Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Gastrointestinal Products Market, by Devices

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
  • 5.3. Endoscopy
    • 5.3.1. Global Gastrointestinal Products Market, by Endoscopy, by Region, 2020-2034(USD Billion)
    • 5.3.2. Colonoscopy
      • 5.3.2.1. Global Gastrointestinal Products Market, by Colonoscopy, by Region, 2020-2034(USD Billion)
    • 5.3.3. Sigmoidoscopes
      • 5.3.3.1. Global Gastrointestinal Products Market, by Sigmoidoscopes, by Region, 2020-2034(USD Billion)
    • 5.3.4. Capsule endoscopy systems
      • 5.3.4.1. Global Gastrointestinal Products Market, by Capsule endoscopy systems, by Region, 2020-2034(USD Billion)
    • 5.3.5. Other endoscopy devices/accessories
      • 5.3.5.1. Global Gastrointestinal Products Market, by Other endoscopy devices/accessories, by Region, 2020-2034(USD Billion)
  • 5.4. Ablation system
    • 5.4.1. Global Gastrointestinal Products Market, by Ablation system, by Region, 2020-2034(USD Billion)
    • 5.4.2. Radiofrequency Ablation system
      • 5.4.2.1. Global Gastrointestinal Products Market, by Radiofrequency Ablation system, by Region, 2020-2034(USD Billion)
    • 5.4.3. Microwave Ablation system
      • 5.4.3.1. Global Gastrointestinal Products Market, by Microwave Ablation system, by Region, 2020-2034(USD Billion)
    • 5.4.4. Cryoablation system
      • 5.4.4.1. Global Gastrointestinal Products Market, by Cryoablation system, by Region, 2020-2034(USD Billion)
    • 5.4.5. Other ablation system
      • 5.4.5.1. Global Gastrointestinal Products Market, by Other ablation system, by Region, 2020-2034(USD Billion)
  • 5.5. Motility testing
    • 5.5.1. Global Gastrointestinal Products Market, by Motility testing, by Region, 2020-2034(USD Billion)
    • 5.5.2. Esophageal Manometry
      • 5.5.2.1. Global Gastrointestinal Products Market, by Esophageal Manometry, by Region, 2020-2034(USD Billion)
    • 5.5.3. 4-hour pH impedance testing
      • 5.5.3.1. Global Gastrointestinal Products Market, by 4-hour pH impedance testing, by Region, 2020-2034(USD Billion)
    • 5.5.4. Anorectal Manometry
      • 5.5.4.1. Global Gastrointestinal Products Market, by Anorectal Manometry, by Region, 2020-2034(USD Billion)
    • 5.5.5. Other Motility testing
      • 5.5.5.1. Global Gastrointestinal Products Market, by Other Motility testing, by Region, 2020-2034(USD Billion)
  • 5.6. Biopsy Devices
    • 5.6.1. Global Gastrointestinal Products Market, by Biopsy Devices, by Region, 2020-2034(USD Billion)
    • 5.6.2. Needle Biopsy Devices
      • 5.6.2.1. Global Gastrointestinal Products Market, by Needle Biopsy Devices, by Region, 2020-2034(USD Billion)
    • 5.6.3. Endoscopic mucosal resection (EMR) devices
      • 5.6.3.1. Global Gastrointestinal Products Market, by Endoscopic mucosal resection (EMR) devices, by Region, 2020-2034(USD Billion)
    • 5.6.4. Endoscopic submucosal dissection (ESD) devices
      • 5.6.4.1. Global Gastrointestinal Products Market, by Endoscopic submucosal dissection (EMR) devices, by Region, 2020-2034(USD Billion)
    • 5.6.5. Other Biopsy accessory products
      • 5.6.5.1. Global Gastrointestinal Products Market, by Other Biopsy accessory products devices, by Region, 2020-2034(USD Billion)
  • 5.7. Stenting Devices
    • 5.7.1. Global Gastrointestinal Products Market, by Stenting Devices, by Region, 2020-2034(USD Billion)
  • 5.8. pH monitoring devices
    • 5.8.1. Global Gastrointestinal Products Market, by pH monitoring devices, by Region, 2020-2034(USD Billion)
  • 5.9. Other gastroenterology devices
    • 5.9.1. Global Gastrointestinal Products Market, by Other gastroenterology devices, by Region, 2020-2034(USD Billion)

6. Global Gastrointestinal Products Market, by Disease

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
  • 6.3. INFLAMMATORY BOWEL DISEASE (IBD)
    • 6.3.1. Global Gastrointestinal Products Market, by INFLAMMATORY BOWEL DISEASE (IBD), by Region, 2020-2034(USD Billion)
  • 6.4. GASTROESOPHAGEAL REFLUX DISEASE (GERD)
    • 6.4.1. Global Gastrointestinal Products Market, by GASTROESOPHAGEAL REFLUX DISEASE (GERD), by Region, 2020-2034(USD Billion)
  • 6.5. Irritable bowel syndrome (IBS)
    • 6.5.1. Global Gastrointestinal Products Market, by Irritable bowel syndrome (IBS), by Region, 2020-2034(USD Billion)
  • 6.6. Gastrointestinal cancer
    • 6.6.1. Global Gastrointestinal Products Market, by Gastrointestinal cancer, by Region, 2020-2034(USD Billion)
  • 6.7. Other Diseases
    • 6.7.1. Global Gastrointestinal Products Market, by Other Diseases, by Region, 2020-2034(USD Billion)

7. Global Gastrointestinal Products Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Gastrointestinal Products Market, by Hospitals, by Region, 2020-2034(USD Billion)
  • 7.4. Ambulatory surgical centres and Independent diagnostic centres
    • 7.4.1. Global Gastrointestinal Products Market, by Ambulatory surgical centres and Independent diagnostic centres, by Region, 2020-2034(USD Billion)
  • 7.5. Clinics
    • 7.5.1. Global Gastrointestinal Products Market, by Clinics, by Region, 2020-2034(USD Billion)
  • 7.6. Other End Users
    • 7.6.1. Global Gastrointestinal Products Market, by Other End Users, by Region, 2020-2034(USD Billion)

8. Global Gastrointestinal Products Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Gastrointestinal Products Market Assessment, By Geography, 2020-2034(USD Billion)
  • 8.3. Gastrointestinal Products Market - North America
    • 8.3.1. North America: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
    • 8.3.2. North America: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
    • 8.3.3. North America: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.3.4. Gastrointestinal Products Market - US
      • 8.3.4.1. US: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.3.4.2. US: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.3.4.3. US: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.3.5. Gastrointestinal Products Market - Canada
      • 8.3.5.1. Canada: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.3.5.2. Canada: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.3.5.3. Canada: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
  • 8.4. Gastrointestinal Products Market - Europe
    • 8.4.1. Europe: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
    • 8.4.2. Europe: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
    • 8.4.3. Europe: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.4.4. Gastrointestinal Products Market - UK
      • 8.4.4.1. UK: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.4.4.2. UK: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.4.4.3. UK: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.4.5. Gastrointestinal Products Market - France
      • 8.4.5.1. France: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.4.5.2. France: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.4.5.3. France: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.4.6. Gastrointestinal Products Market - Germany
      • 8.4.6.1. Germany: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.4.6.2. Germany: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.4.6.3. Germany: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.4.7. Gastrointestinal Products Market - Italy
      • 8.4.7.1. Italy: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.4.7.2. Italy: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.4.7.3. Italy: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.4.8. Gastrointestinal Products Market - Spain
      • 8.4.8.1. Spain: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.4.8.2. Spain: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.4.8.3. Spain: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.4.9. Gastrointestinal Products Market - Netherlands
      • 8.4.9.1. Netherlands: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.4.9.2. Netherlands: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.4.9.3. Netherlands: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.4.10. Gastrointestinal Products Market - Russia
      • 8.4.10.1. Russia: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.4.10.2. Russia: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.4.10.3. Russia: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.4.11. Gastrointestinal Products Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.4.11.2. Rest of Europe: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.4.11.3. Rest of Europe: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
  • 8.5. Gastrointestinal Products Market - Asia Pacific
    • 8.5.1. Asia Pacific: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
    • 8.5.2. Asia Pacific: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
    • 8.5.3. Asia Pacific: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.5.4. Gastrointestinal Products Market - China
      • 8.5.4.1. China: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.5.4.2. China: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.5.4.3. China: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.5.5. Gastrointestinal Products Market - India
      • 8.5.5.1. India: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.5.5.2. India: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.5.5.3. India: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.5.6. Gastrointestinal Products Market - Malaysia
      • 8.5.6.1. Malaysia: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.5.6.2. Malaysia: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.5.6.3. Malaysia: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.5.7. Gastrointestinal Products Market - Japan
      • 8.5.7.1. Japan: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.5.7.2. Japan: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.5.7.3. Japan: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.5.8. Gastrointestinal Products Market - Indonesia
      • 8.5.8.1. Indonesia: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.5.8.2. Indonesia: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.5.8.3. Indonesia: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.5.9. Gastrointestinal Products Market - South Korea
      • 8.5.9.1. South Korea: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.5.9.2. South Korea: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.5.9.3. South Korea: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.5.10. Gastrointestinal Products Market - Australia
      • 8.5.10.1. Australia: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.5.10.2. Australia: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.5.10.3. Australia: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.5.11. Gastrointestinal Products Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
  • 8.6. Gastrointestinal Products Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
    • 8.6.2. Middle East & Africa: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
    • 8.6.3. Middle East & Africa: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.6.4. Gastrointestinal Products Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.6.4.2. Saudi Arabia: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.6.4.3. Saudi Arabia: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.6.5. Gastrointestinal Products Market - UAE
      • 8.6.5.1. UAE: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.6.5.2. UAE: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.6.5.3. UAE: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.6.6. Gastrointestinal Products Market - Israel
      • 8.6.6.1. Israel: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.6.6.2. Israel: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.6.6.3. Israel: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.6.7. Gastrointestinal Products Market - South Africa
      • 8.6.7.1. South Africa: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.6.7.2. South Africa: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.6.7.3. South Africa: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.6.8. Gastrointestinal Products Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
  • 8.7. Gastrointestinal Products Market - Latin America
    • 8.7.1. Latin America: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
    • 8.7.2. Latin America: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
    • 8.7.3. Latin America: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.7.4. Gastrointestinal Products Market - Mexico
      • 8.7.4.1. Mexico: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.7.4.2. Mexico: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.7.4.3. Mexico: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.7.5. Gastrointestinal Products Market - Brazil
      • 8.7.5.1. Brazil: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.7.5.2. Brazil: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.7.5.3. Brazil: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.7.6. Gastrointestinal Products Market - Argentina
      • 8.7.6.1. Argentina: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.7.6.2. Argentina: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.7.6.3. Argentina: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
    • 8.7.7. Gastrointestinal Products Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
      • 8.7.7.2. Rest of Latin America: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
      • 8.7.7.3. Rest of Latin America: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Devices Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Johnson & Johnson
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Devices Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Pfizer Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Devices Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bayer AG
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Devices Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Astellas Pharma Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Devices Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Takeda Pharmaceutical Company
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Devices Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Novartis International AG
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Devices Benchmarking
    • 10.7.4. Recent Development
  • 10.8. GSK (GlaxoSmithKline)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Devices Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Mylan N.V.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Devices Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Santen Pharmaceutical Co., Ltd.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Devices Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Dr. Reddy's Laboratories Ltd.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Devices Benchmarking
    • 10.11.4. Recent Development
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제